Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OYST
3901
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $80K | ﹤0.01% |
18,500
+4,300
| +30% | +$24.4K |
|
3902
Eledon Pharmaceuticals
ELDN
$291M
| $79K | ﹤0.01% |
32,173
+13,700
| +74% | +$41.8K |
|
|
FEED
3903
ENvue Medical Inc
FEED
$3.79M
| $79K | ﹤0.01% |
57
-77
| -57% | -$121K |
|
3904
Cipher Digital
CIFR
$7.42B
| $78K | ﹤0.01% |
56,800
-269,937
| -83% | -$658K |
|
3905
Upexi
UPXI
$60.5M
| $78K | ﹤0.01% |
+930
| New | +$87.6K |
|
|
LHDX
3906
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $78K | ﹤0.01% |
+41,800
| New | +$102K |
|
|
BLCT
3907
DELISTED
BlueCity Holdings Limited American Depositary Shares
BLCT
| $78K | ﹤0.01% |
52,700
+29,500
| +127% | +$39.4K |
|
3908
Redwire
RDW
$3.37B
| $77K | ﹤0.01% |
+25,480
| New | +$123K |
|
|
FGNX
3909
FG Nexus Inc
FGNX
$40.2M
| $76K | ﹤0.01% |
418
+3
| +0.7% | +$1.03K |
|
3910
Newegg Commerce
NEGG
$415M
| $76K | ﹤0.01% |
+1,036
| New | +$109K |
|
|
XIN
3911
DELISTED
Xinyuan Real Estate
XIN
| $76K | ﹤0.01% |
9,480
-50
| -0.5% | -$501 |
|
3912
SELLAS Life Sciences
SLS
$2.31B
| $75K | ﹤0.01% |
+33,838
| New | +$99.2K |
|
3913
cbdMD
YCBD
$6.28M
| $75K | ﹤0.01% |
475
+215
| +83% | +$50.9K |
|
3914
Edesa Biotech
EDSA
$51.1M
| $74K | ﹤0.01% |
6,607
-5,222
| -44% | -$77K |
|
|
CHRN
3915
ChronoScale Holdings
CHRN
$3.02B
| $74K | ﹤0.01% |
2,974
+1,801
| +154% | +$57.2K |
|
3916
Intelligent Bio Solutions
INBS
$6.08M
| $74K | ﹤0.01% |
47
+19
| +68% | +$32K |
|
3917
Mediaco Holding
MDIA
$78.3M
| $74K | ﹤0.01% |
35,100
-25,600
| -42% | -$73.1K |
|
|
EQOS
3918
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
| $74K | ﹤0.01% |
88,659
+57,459
| +184% | +$76.6K |
|
|
BHAT
3919
DELISTED
Blue Hat Interactive Entertainment Technology
BHAT
| $73K | ﹤0.01% |
5
+1
| +25% | +$13.6K |
|
|
KORE
3920
DELISTED
KORE Group Holdings
KORE
| $73K | ﹤0.01% |
+4,740
| New | +$106K |
|
3921
Mind CTI
MNDO
$20.6M
| $73K | ﹤0.01% |
30,700
-30,325
| -50% | -$78.1K |
|
3922
Oragenics
OGEN
$2.42M
| $73K | ﹤0.01% |
116
+62
| +115% | +$35.8K |
|
3923
Oxbridge Re Holdings
OXBR
$9.64M
| $73K | ﹤0.01% |
22,000
+1,118
| +5% | +$5.29K |
|
|
ALP
3924
Alpha Compute
ALP
$4.22M
| $73K | ﹤0.01% |
526
-1,339
| -72% | -$195K |
|
|
VBIO
3925
Valion Bio
VBIO
$938K
| $73K | ﹤0.01% |
22
-50
| -69% | -$147K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.